Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (611-620 of 672) with videos related to

Pageof 68
Sort By:
Molecular Cancer Therapeutics|October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 miceSomnath Shee, Meixiang Huang, Meghraj Singh Baghel, et al.
Pain|May 13, 2014
Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in miceZhe Li, Shao-Qiu He, Qian Xu, et al.
Pharmaceutics|October 27, 2022
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in MiceCarolyn Tallon, Benjamin J Bell, Anjali Sharma, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
Development of novel tools for dissection of central versus peripheral dopamine D<sub>2</sub>-like receptor signaling in dysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Diabetes|June 13, 2024
Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in DysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2025
Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficitsMeixiang Huang, Yannan Li, Ajit G Thomas, et al.
Pediatric Research|September 9, 2023
Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort studyRose Gelineau-Morel, Fatima Usman, Saadatu Shehu, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Pageof 68

Showing results (611-620 of 672) with videos related to

Sort By:
Pageof 68
Molecular Cancer Therapeutics|October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 miceSomnath Shee, Meixiang Huang, Meghraj Singh Baghel, et al.
Pain|May 13, 2014
Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in miceZhe Li, Shao-Qiu He, Qian Xu, et al.
Pharmaceutics|October 27, 2022
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in MiceCarolyn Tallon, Benjamin J Bell, Anjali Sharma, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
Development of novel tools for dissection of central versus peripheral dopamine D<sub>2</sub>-like receptor signaling in dysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Diabetes|June 13, 2024
Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in DysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2025
Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficitsMeixiang Huang, Yannan Li, Ajit G Thomas, et al.
Pediatric Research|September 9, 2023
Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort studyRose Gelineau-Morel, Fatima Usman, Saadatu Shehu, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Pageof 68